The complex diagnosis of Cushing’s syndrome

In this engaging podcast about the diagnosis of Cushing's syndrome, Pituitary Worlds News co-founder and Medical Director, California Center for Pituitary Disorders at UCSF Professor...

From the European Society of Endocrinology: Cushing’s syndrome clinical management guidance during the...

This is a series of urgent clinical guidance documents on the management of endocrine conditions in the time of COVID-19. This clinical guidance document...

A new drug for Cushing’s: Learn more

In this podcast, Dr. Lewis Blevins discusses a new drug for Cushing's disease recently approved in the US.  

Podcast: Critical COVID-19 information for pituitary patients

We caught up with Dr. Kevin Yuen, medical director of the Barrow Pituitary Center and the Barrow Neuroendocrinology Clinic in Phoenix, Arizona, and  Dr. Lewis...

From our friends at the Pacific Neuroscience Institute: Cushing’s 101

This article on Cushing’s disease provides a concise, excellent overview of the optimal management and highlights of both surgical and medical advances. Click here...
video

Touching patient journeys from CSRF (Cushing’s Support & Research Foundation)

From the Desk of Leslie Edwin, President of CSRF and PWN Contributor - We have just completed an intimate, four-video series of first-hand accounts of...

1 – Exploration, Innovation and Creativity: An intimate look at new drug development...

This is the first in a series of 6 podcasts on the ins and outs of drug development.  In it, we discuss the journey that...

Educational resources from the Cushing’s Support and Research Foundation

The CSRF has published materials from their recent Patient Journey Summit,"Defining the New Normal” The topics for the conference, held October 4-6, 2019 at Emory...

WAPO participates in Cushing’s Patient Journey Summit 2019

The World Alliance of Pituitary Organizations (WAPO) will participate in the upcoming Cushing's Support and Research Foundation (CSRF) conference slated for October 4 to...

Positive news for new Cushing’s drug

In a press release, Strongbridge Biopharma announced comprehensive positive results of their Phase 3 SONICS study of RECORLEVTM (levoketoconazole) for the potential treatment of...

NEWS YOU CAN USE

Articles you may like